Protease Inhibitors

A cell-permeable pentacyclic triterpenoid from birch bark extract that interacts with SCAP (SREBP cleavage activating protein) and prevents SREBP (sterol regulatory element-binding protein) Golgi proteolytic activation (1 to 13.55 &#181M in Rat

A cell-permeable, non-phosphorylated inactive control peptide for STAT3 cellular function studies utilizing STAT3 Inhibitor PpYLKTK-mts (Cat. No.

A water soluble (32 &#181M in water) BBB-permeable ATPZ (aminothienopyridazine) tau aggregation inhibitor that exhibited IC 50 of 8.1 &#181M in a heparin-induced tau assembly assay (monitored by thioflavine-T binding and fluorescence), and was

Egg white trypsin inhibitor is an inhibitor for trypsin, plasmin and plasma kallikrein activity in serum-free cell-culture media. It does not inhibit metallo-, cysteine, and aspartic proteases or tissue kallikrein (serine protease).

A macrocyclic 17-amino acid peptide derived from residues 79 - 93 of vascular endothelial growth factor that mediate its binding to VEGFR-2. It blocks the binding of VEGF 165 to its receptors (IC 50 = 700 nM for VEGFR1, 1.

An NRP-1-binding heptapeptide whose target was initially mistaken as VEGFR2/KDR/Flk-1 due to its binding activity to a CHO-KDR culture that was later shown to express primarily NRP-1 and little KDR. V1/A7R specifically competes against VEGF 165